Kestra Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.48M Sell
22,291
-7,986
-26% -$1.65M 0.02% 856
2025
Q4
$6.25M Buy
30,277
+12,344
+69% +$2.47M 0.03% 606
2025
Q3
$3.22M Buy
17,933
+1,647
+10% +$280K 0.01% 919
2025
Q2
$2.63M Sell
16,286
-335
-2% -$53.4K 0.01% 939
2025
Q1
$2.83M Sell
16,621
-2,570
-13% -$446K 0.01% 827
2024
Q4
$3.19M Buy
19,191
+8,669
+82% +$1.48M 0.02% 772
2024
Q3
$1.81M Sell
10,522
-547
-5% -$90.5K 0.01% 1000
2024
Q2
$1.7M Sell
11,069
-8,354
-43% -$1.25M 0.01% 1043
2024
Q1
$2.99M Buy
19,423
+4,694
+32% +$716K 0.02% 708
2023
Q4
$2.33M Sell
14,729
-1,818
-11% -$261K 0.02% 733
2023
Q3
$2.42M Buy
16,547
+680
+4% +$104K 0.02% 624
2023
Q2
$2.43M Sell
15,867
-971
-6% -$151K 0.02% 606
2023
Q1
$2.61M Buy
16,838
+252
+2% +$39.6K 0.03% 554
2022
Q4
$2.56M Buy
16,586
+3,369
+25% +$497K 0.02% 646
2022
Q3
$1.74M Sell
13,217
-28
-0.2% -$3.93K 0.02% 726
2022
Q2
$1.79M Sell
13,245
-2,394
-15% -$330K 0.02% 713
2022
Q1
$2.33M Sell
15,639
-5,194
-25% -$768K 0.02% 620
2021
Q4
$3.37M Sell
20,833
-1,809
-8% -$293K 0.03% 497
2021
Q3
$3.76M Sell
22,642
-14,232
-39% -$2.43M 0.04% 482
2021
Q2
$6.37M Sell
36,874
-3,425
-8% -$566K 0.07% 304
2021
Q1
$6.47M Sell
40,299
-9,755
-19% -$1.67M 0.08% 276
2020
Q4
$8.47M Buy
50,054
+6,902
+16% +$1.12M 0.1% 231
2020
Q3
$6.8M Buy
+43,152
New +$7.05M 0.13% 193

Other funds holding FBT